Introduction
IGF-LR3 (Insulin-like Growth Factor Long R3) is a synthetic peptide that is structurally similar to insulin. It is a modified version of insulin-like growth factor (IGF-1) and is thought to be more potent than native IGF-1.
What is IGF-LR3?
How does IGF-LR3 work?
IGF-LR3 is a synthetic peptide that is structurally similar to insulin and is derived from an insulin-like growth factor (IGF-1). It is a modified version of IGF-1 with a longer half-life and increased potency. It is used to increase muscle growth, strength and recovery, as well as to improve overall health and well-being.
IGF-LR3 works by binding to the IGF-1 receptor in cells, which leads to the activation of intracellular signalling pathways. These pathways promote cell growth and division, which can increase muscle mass, strength and recovery. It also has anabolic effects on bone and other tissues, promoting overall health and well-being.
What are the potential benefits of IGF-LR3?
The potential benefits of IGF-LR3 include increased muscle growth, strength, and recovery, as well as improved overall health and well-being. Additionally, it may help treat conditions such as muscle wasting diseases and age-related muscle loss.
What are the potential side effects of IGF-LR3?
IGF-LR3 is generally considered to be safe and well-tolerated when used as directed. However, some people may experience side effects such as headaches, muscle pain, and water retention. Additionally, long-term use and high dosages of IGF-LR3 may increase insulin levels.
Research Dosage:
In human trials, the dosage of IGF-LR3 has varied depending on the specific study and the research goals. The dosages used in human studies have ranged from 50mcg to 200mcg per
References:
- IGF-1 Long R3. (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK56960/
- Insulin-Like Growth Factor 1 (IGF-1). (n.d.). Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28787926
- Insulin-Like Growth Factor 1 (IGF-1). (n.d.). Retrieved from https://www.uniprot.org/uniprot/P08069
